
The information displayed in the AIM should not be reported as representing the official views of the OECD or of its member countries.
The Trump administration is advancing efforts to integrate AI chatbots and diagnostic tools into American healthcare, with Amy Gleason leading the initiative after a personal success using ChatGPT for her daughter's diagnosis. Experts warn of potential misdiagnoses and patient harm, citing low diagnostic accuracy and regulatory risks, though no actual harm has yet occurred.[AI generated]





























